LabCorp(R) Announces Results of its Offer to Purchase Zero-Coupon Subordinated Notes Due 2021

BURLINGTON, N.C., Sept. 13 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that no holders of its zero coupon-subordinated notes elected to exercise their option to redeem their notes on September 11, 2004.

LabCorp(R) Scheduled to Present at the Thomas Weisel Partners Health Care Conference

BURLINGTON, N.C., Sept. 8 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the Thomas Weisel Partners Health Care Conference in Boston, MA

Arthur H. Rubenstein Named to LabCorp(R) Board of Directors

BURLINGTON, N.C., Aug. 2 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Arthur H. Rubenstein, MBBCh, has been elected to its Board of Directors, effective August 1, 2004. Dr. Rubenstein, 66, is the Dean of the University of

Laboratory Corporation of America(R) Announces 2004 Second Quarter Results

EPS Increases 16.7 Percent to $0.70; EBITDA Margin Hits 26.9 Percent of Net Sales; Operating Cash Flow Increases 19 Percent; Company Increases Annual EPS Guidance for 2004 BURLINGTON, N.C., July 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today

LabCorp(R) Announces New Non-Invasive Swab Test for Alpha1-Antitrypsin Deficiency

One in 12 People Have AAT Deficiency Gene; Early Detection Can Lead to Prevention or Reduction of Chronic Disease BURLINGTON, N.C., May 20 /PRNewswire-FirstCall/ -- Laboratory Corporation of America Holdings (LabCorp(R)) (NYSE: LH) today announced the offering of the only buccal swab test for

LabCorp(R) Scheduled to Present at the Banc of America Securities Health Care Conference

BURLINGTON, N.C., May 19 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Thomas P. Mac Mahon, Chairman and Chief Executive Officer, is scheduled to speak at the Banc of America Securities Health Care Conference in Las Vegas, NV on

Laboratory Corporation of America(R) Announces 2004 First Quarter Results

EPS Increases 19.6 Percent to $0.61, EBITDA Margin Hits 25.4 Percent of Net Sales, Operating Cash Flow Grows 9.3 Percent to $147.6 Million BURLINGTON, N.C., April 22 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced results for the

LabCorp(R) Announces U.S. Launch of Exclusive Liver Fibrosis Assay HCV FibroSURE(TM)

Noninvasive Blood Test Provides Alternative to Liver Biopsy for Assessing Status of Hepatitis C Patients BURLINGTON, N.C., March 17 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the availability of HCV FibroSURE(TM), a noninvasive

LabCorp(R) Scheduled to Present at the SG Cowen Annual Health Care Conference

BURLINGTON, N.C., March 10 /PRNewswire-FirstCall/ -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that Bradford T. Smith, executive vice president of corporate affairs, is scheduled to speak at the SG Cowen Annual Health Care Conference in Boston, MA on

LabCorp(R) Signs Multi-Year Definitive Agreement to Provide Laboratory Services to All Swedish Medical Center Facilities

Long-Term Contract Expands Current Business Relationship Through 2015 BURLINGTON, N.C., Mar 4, 2004 /PRNewswire-FirstCall via COMTEX/ -- Laboratory Corporation of America Holdings (LabCorp(R)) (NYSE: LH) today announced a definitive agreement with Swedish Medical Center, one of the largest and most